SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 28, 2006
Commission File No. 0-9989
SUNOPTA INC.
(Exact name of registrant as specified in its charter)
CANADA
(Jurisdiction of Incorporation)
Not Applicable
(I.R.S. Employer Identification No.)
2838 Bovaird Drive West
Brampton, Ontario, L7A 0H2, Canada
(Address of Principal Executive Offices)
(905) 455-1990
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
SUNOPTA INC.
FORM 8-K
ITEM 8.01 OTHER EVENTS
On November 28, 2006, SunOpta Inc. issued a press release in accordance with Securities Act Rule 135c relating to the engagement of two investment banks to raise equity capital for its BioProcess Division. A copy of the press release is attached to this Form 8-K as Exhibit 99.1.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(a) Not applicable
(b) Not applicable
(c) Not applicable
(d) Exhibits
| Exhibit No. | Description | |||
| 99.1 | Press release dated November 28, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SUNOPTA INC. | |||
| By | /s/ Jeremy N. Kendall | By | /s/ John Dietrich |
| Jeremy N. Kendall, | John Dietrich, | ||
| Chairman and Chief Executive Officer | Vice President and Chief Financial Officer | ||
| Date | November 28, 2006 | Date | November 28, 2006 |